Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Free Cash Flow (2017 - 2025)

Neuronetics (STIM) has disclosed Free Cash Flow for 9 consecutive years, with -$806000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow rose 87.79% to -$806000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$28.5 million, a 26.95% decrease, with the full-year FY2024 number at -$31.0 million, up 9.76% from a year prior.
  • Free Cash Flow was -$806000.0 for Q3 2025 at Neuronetics, up from -$3.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $1.3 million in Q4 2023 to a low of -$17.0 million in Q1 2025.
  • A 5-year average of -$7.8 million and a median of -$8.2 million in 2022 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: skyrocketed 395.65% in 2023, then crashed 659.98% in 2024.
  • Neuronetics' Free Cash Flow stood at -$6.5 million in 2021, then skyrocketed by 93.27% to -$437000.0 in 2022, then surged by 395.65% to $1.3 million in 2023, then plummeted by 659.98% to -$7.2 million in 2024, then skyrocketed by 88.86% to -$806000.0 in 2025.
  • Per Business Quant, the three most recent readings for STIM's Free Cash Flow are -$806000.0 (Q3 2025), -$3.5 million (Q2 2025), and -$17.0 million (Q1 2025).